VAXART, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8664 USD | -3.67% |
|
-9.64% | +51.26% |
| 05-13 | Transcript : Vaxart, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
| 05-13 | Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VAXART, INC. | Bio Therapeutic Drugs | -3.67% | -9.64% | +51.26% | -28.40% | +27.41% | 153M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VXRT Stock
- Charts Vaxart, Inc.
- Comparison Chart
